Norman Francis Kirkby
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Norman Francis Kirkby has a total of 113 co-authors. Here are the top co-authors by number of shared publications:
- Karen Joy Kirkby
Division of Cancer Sciences, The University of Manchester, 3rd Floor Proton Beam Therapy Centre, The Christie NHS Foundation Trust, Oak Road, Manchester, M20 3DA, UNITED KINGDOM OF GREAT BRITAIN AND NORTHERN IRELAND
10 shared publications - Neil Gunn Burnet
Proton Centre, The Christie NHS Foundation Trust, Manchester, UK
8 shared publications R. Jena
5 shared publicationsRaj Jena
Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, CB2 0QQ, UK
5 shared publications- Roger P. Webb
Ion Beam Centre Advanced Technology Institute University of Surrey Guildford GU2 7XH UK
5 shared publications E. Alpay
Department of Chemical Engineering and Chemical Technology, Imperial College of Science, Technology and Medicine, Prince Consort Road, London SW7 2BY, UK
4 shared publications
Latest Publications
- 1 January 2017
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 122 (1) , 159-162
Using the Malthus programme to predict the recruitment of patients to MR-linac research trials in prostate and lung cancer
- 1 January 2017
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 122 (1) , 159-162
Using the Malthus programme to predict the recruitment of patients to MR-linac research trials in prostate and lung cancer
- 23 February 2016
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 61 (5) , 2145-2161
Modelling and Bayesian adaptive prediction of individual patients’ tumour volume change during radiotherapy
The aim of this study is to develop a mathematical modelling method that can predict individual patients’ response to radiotherapy, in terms of tumour volume change during the treatment. The main concept is to start from a population-average model, which is subsequently updated from an individual’s tumour volume measurement. The model becomes increasingly personalised and so too does the prediction it produces. This idea of adaptive prediction was realised by using a Bayesian approach for updating the model parameters. The feasibility of the developed method was demonstrated on the data from 25 non-small cell lung cancer patients treated with helical tomotherapy, during which tumour volume was measured from daily imaging as part of the image-guided radiotherapy. The method could provide useful information for adaptive treatment planning and dose scheduling based on the patient’s personalised response.
- 23 February 2016
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 61 (5) , 2145-2161
Modelling and Bayesian adaptive prediction of individual patients’ tumour volume change during radiotherapy
The aim of this study is to develop a mathematical modelling method that can predict individual patients’ response to radiotherapy, in terms of tumour volume change during the treatment. The main concept is to start from a population-average model, which is subsequently updated from an individual’s tumour volume measurement. The model becomes increasingly personalised and so too does the prediction it produces. This idea of adaptive prediction was realised by using a Bayesian approach for updating the model parameters. The feasibility of the developed method was demonstrated on the data from 25 non-small cell lung cancer patients treated with helical tomotherapy, during which tumour volume was measured from daily imaging as part of the image-guided radiotherapy. The method could provide useful information for adaptive treatment planning and dose scheduling based on the patient’s personalised response.
- 3 August 2015
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 60 (16) , 6289-6303
Automatic cell detection in bright-field microscopy for microbeam irradiation studies
Automatic cell detection in bright-field illumination microscopy is challenging due to cells’ inherent optical properties. Applications including individual cell microbeam irradiation demand minimisation of additional cell stressing factors, so contrast-enhancing fluorescence microscopy should be avoided. Additionally, the use of optically non-homogeneous substrates amplifies the problem. This research focuses on the design of a method for automatic cell detection on polypropylene substrate, suitable for microbeam irradiation. In order to fulfil the relative requirements, the Harris corner detector was employed to detect apparent cellular features. These features-corners were clustered based on a dual-clustering technique according to the density of their distribution across the image. Weighted centroids were extracted from the clusters of corners and constituted the targets for irradiation. The proposed method identified more than 88% of the 1,738 V79 Chinese hamster cells examined. Moreover, a processing time of 2.6 s per image fulfilled the requirements for a near real-time cell detection-irradiation system.
- 3 August 2015
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 60 (16) , 6289-6303
Automatic cell detection in bright-field microscopy for microbeam irradiation studies
Automatic cell detection in bright-field illumination microscopy is challenging due to cells’ inherent optical properties. Applications including individual cell microbeam irradiation demand minimisation of additional cell stressing factors, so contrast-enhancing fluorescence microscopy should be avoided. Additionally, the use of optically non-homogeneous substrates amplifies the problem. This research focuses on the design of a method for automatic cell detection on polypropylene substrate, suitable for microbeam irradiation. In order to fulfil the relative requirements, the Harris corner detector was employed to detect apparent cellular features. These features-corners were clustered based on a dual-clustering technique according to the density of their distribution across the image. Weighted centroids were extracted from the clusters of corners and constituted the targets for irradiation. The proposed method identified more than 88% of the 1,738 V79 Chinese hamster cells examined. Moreover, a processing time of 2.6 s per image fulfilled the requirements for a near real-time cell detection-irradiation system.
- 17 April 2015
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 60 (9) , 3695-3713
Mathematical modelling of tumour volume dynamics in response to stereotactic ablative radiotherapy for non-small cell lung cancer
This paper reports a modelling study of tumour volume dynamics in response to stereotactic ablative radiotherapy (SABR). The main objective was to develop a model that is adequate to describe tumour volume change measured during SABR, and at the same time is not excessively complex as lacking support from clinical data. To this end, various modelling options were explored, and a rigorous statistical method, the Akaike information criterion, was used to help determine a trade-off between model accuracy and complexity. The models were calibrated to the data from 11 non-small cell lung cancer patients treated with SABR. The results showed that it is feasible to model the tumour volume dynamics during SABR, opening up the potential for using such models in a clinical environment in the future.
- 17 April 2015
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 60 (9) , 3695-3713
Mathematical modelling of tumour volume dynamics in response to stereotactic ablative radiotherapy for non-small cell lung cancer
This paper reports a modelling study of tumour volume dynamics in response to stereotactic ablative radiotherapy (SABR). The main objective was to develop a model that is adequate to describe tumour volume change measured during SABR, and at the same time is not excessively complex as lacking support from clinical data. To this end, various modelling options were explored, and a rigorous statistical method, the Akaike information criterion, was used to help determine a trade-off between model accuracy and complexity. The models were calibrated to the data from 11 non-small cell lung cancer patients treated with SABR. The results showed that it is feasible to model the tumour volume dynamics during SABR, opening up the potential for using such models in a clinical environment in the future.
- Open Access
- 1 January 2014
- Published by Elsevier in Waste Management
- Vol. 34 (1) , 185-195
Environmental & economic life cycle assessment of current & future sewage sludge to energy technologies
- 1 January 2014
- Published by Elsevier in Waste Management
- Vol. 34 (1) , 185-195
Open AccessEnvironmental & economic life cycle assessment of current & future sewage sludge to energy technologies
- 1 September 2013
- Published by Elsevier in Clinical Oncology
- Vol. 25 (9) , 522-530
Radiotherapy Demand and Activity in England 2006–2020
- 1 September 2013
- Published by Elsevier in Clinical Oncology
- Vol. 25 (9) , 522-530
Radiotherapy Demand and Activity in England 2006–2020
- Open Access
- 1 July 2013
- Published by Oxford University Press (OUP) in Journal of Radiation Research
- Vol. 54 (suppl 1) , i49-i55
Data-driven Markov models and their application in the evaluation of adverse events in radiotherapy
Decision-making processes in medicine rely increasingly on modelling and simulation techniques; they are especially useful when combining evidence from multiple sources. Markov models are frequently used to synthesize the available evidence for such simulation studies, by describing disease and treatment progress, as well as associated factors such as the treatment's effects on a patient's life and the costs to society. When the same decision problem is investigated by multiple stakeholders, differing modelling assumptions are often applied, making synthesis and interpretation of the results difficult. This paper proposes a standardized approach towards the creation of Markov models. It introduces the notion of ‘general Markov models’, providing a common definition of the Markov models that underlie many similar decision problems, and develops a language for their specification. We demonstrate the application of this language by developing a general Markov model for adverse event analysis in radiotherapy and argue that the proposed method can automate the creation of Markov models from existing data. The approach has the potential to support the radiotherapy community in conducting systematic analyses involving predictive modelling of existing and upcoming radiotherapy data. We expect it to facilitate the application of modelling techniques in medical decision problems beyond the field of radiotherapy, and to improve the comparability of their results.
- 1 July 2013
- Published by Oxford University Press (OUP) in Journal of Radiation Research
- Vol. 54 (suppl 1) , i49-i55
Open AccessData-driven Markov models and their application in the evaluation of adverse events in radiotherapy
Decision-making processes in medicine rely increasingly on modelling and simulation techniques; they are especially useful when combining evidence from multiple sources. Markov models are frequently used to synthesize the available evidence for such simulation studies, by describing disease and treatment progress, as well as associated factors such as the treatment's effects on a patient's life and the costs to society. When the same decision problem is investigated by multiple stakeholders, differing modelling assumptions are often applied, making synthesis and interpretation of the results difficult. This paper proposes a standardized approach towards the creation of Markov models. It introduces the notion of ‘general Markov models’, providing a common definition of the Markov models that underlie many similar decision problems, and develops a language for their specification. We demonstrate the application of this language by developing a general Markov model for adverse event analysis in radiotherapy and argue that the proposed method can automate the creation of Markov models from existing data. The approach has the potential to support the radiotherapy community in conducting systematic analyses involving predictive modelling of existing and upcoming radiotherapy data. We expect it to facilitate the application of modelling techniques in medical decision problems beyond the field of radiotherapy, and to improve the comparability of their results.
- Open Access
- 1 July 2013
- Published by Oxford University Press (OUP) in Journal of Radiation Research
- Vol. 54 (suppl 1) , i56-i60
Hadron therapy information sharing prototype
The European PARTNER project developed a prototypical system for sharing hadron therapy data. This system allows doctors and patients to record and report treatment-related events during and after hadron therapy. It presents doctors and statisticians with an integrated view of adverse events across institutions, using open-source components for data federation, semantics, and analysis. There is a particular emphasis upon semantic consistency, achieved through intelligent, annotated form designs. The system as presented is ready for use in a clinical setting, and amenable to further customization. The essential contribution of the work reported here lies in the novel data integration and reporting methods, as well as the approach to software sustainability achieved through the use of community-supported open-source components.
- 1 July 2013
- Published by Oxford University Press (OUP) in Journal of Radiation Research
- Vol. 54 (suppl 1) , i56-i60
Open AccessHadron therapy information sharing prototype
The European PARTNER project developed a prototypical system for sharing hadron therapy data. This system allows doctors and patients to record and report treatment-related events during and after hadron therapy. It presents doctors and statisticians with an integrated view of adverse events across institutions, using open-source components for data federation, semantics, and analysis. There is a particular emphasis upon semantic consistency, achieved through intelligent, annotated form designs. The system as presented is ready for use in a clinical setting, and amenable to further customization. The essential contribution of the work reported here lies in the novel data integration and reporting methods, as well as the approach to software sustainability achieved through the use of community-supported open-source components.
- 21 June 2013
- Published by Elsevier in Clinical Oncology
- Vol. 25 (9) , 538-545
The Malthus Programme: Developing Radiotherapy Demand Models for Breast and Prostate Cancer at the Local, Regional and National Level
- 21 June 2013
- Published by Elsevier in Clinical Oncology
- Vol. 25 (9) , 538-545
The Malthus Programme: Developing Radiotherapy Demand Models for Breast and Prostate Cancer at the Local, Regional and National Level
- Open Access
- 19 March 2013
- Published by Springer Nature in Radiation Oncology
- Vol. 8 (1) , 65
Evaluation of poly (ADP-ribose) polymerase inhibitor ABT-888 combined with radiotherapy and temozolomide in glioblastoma
The cytotoxicity of radiotherapy and chemotherapy can be enhanced by modulating DNA repair. PARP is a family of enzymes required for an efficient base-excision repair of DNA single-strand breaks and inhibition of PARP can prevent the repair of these lesions. The current study investigates the trimodal combination of ABT-888, a potent inhibitor of PARP1-2, ionizing radiation and temozolomide(TMZ)-based chemotherapy in glioblastoma (GBM) cells.
- 19 March 2013
- Published by Springer Nature in Radiation Oncology
- Vol. 8 (1) , 65
Open AccessEvaluation of poly (ADP-ribose) polymerase inhibitor ABT-888 combined with radiotherapy and temozolomide in glioblastoma
The cytotoxicity of radiotherapy and chemotherapy can be enhanced by modulating DNA repair. PARP is a family of enzymes required for an efficient base-excision repair of DNA single-strand breaks and inhibition of PARP can prevent the repair of these lesions. The current study investigates the trimodal combination of ABT-888, a potent inhibitor of PARP1-2, ionizing radiation and temozolomide(TMZ)-based chemotherapy in glioblastoma (GBM) cells.